Literature DB >> 3495975

MR imaging of pulmonary arterial hypertension and pulmonary emboli.

R D White, M L Winkler, C B Higgins.   

Abstract

Intraluminal signal in the pulmonary arteries on spin-echo, ECG-gated MR images is limited to the diastolic phase of the cardiac cycle in normal subjects. Initial experience has indicated that signal persisting during systole may be characteristic of slow blood flow associated with pulmonary arterial hypertension (PAH) or of thrombotic material secondary to pulmonary embolism. This study analyzes our cumulative experience (31 patients) with multiphasic, double spin-echo MR for assessing PAH and/or suspected pulmonary embolism. In PAH, the abnormal systolic signal showed an intensity increase from first to second echo. This pattern was observed in 92% of PAH patients, including 100% of patients with pulmonary systolic pressures greater than or equal to 80 mm Hg and 60% of patients with pressures less than 80 mm Hg. At any focus in the pulmonary arteries, such signal disappeared at some phase of the cardiac cycle. In patients with pulmonary embolism, signal from thrombus was fixed throughout the cardiac cycle and showed little or no increase in relative intensity change from first- to second-echo image. Using this guideline, MR made six confirmed positive and four confirmed negative diagnoses of proximal pulmonary embolism, while it failed to identify thrombus in the one patient with a peripheral pulmonary embolism. Intraluminal signal in the pulmonary arteries caused by PAH or pulmonary embolism can be differentiated in most instances using multiphasic, double spin-echo, ECG-gated MR. However, at its current stage of development, the procedure does not appear to be useful for the evaluation of peripheral pulmonary embolism.

Entities:  

Mesh:

Year:  1987        PMID: 3495975     DOI: 10.2214/ajr.149.1.15

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Venous thromboembolic disease: the use of "optional" inferior vena cava filters.

Authors:  Anthony C Venbrux; Elizabeth A Ignacio; Shawn N Sarin; Amy P Soltes; Noel C Haskins; Dmitri Gagarin
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

2.  Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.

Authors:  S Tsubata; F Ichida; Y Hamamichi; A Miyazaki; I Hashimoto; T Okada
Journal:  Pediatr Cardiol       Date:  1995 Jul-Aug       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.